Feds Escape Suit Over Delayed Narcolepsy Drug
A Washington, D.C., federal judge has allowed the U.S. government to exit drugmaker Avadel's suit over the halted approval of narcolepsy medication Lumryz, finding that there are other avenues of relief...To view the full article, register now.
Already a subscriber? Click here to view full article